New Delhi, June 30 -- Ahmedabad-based drugmaker Torrent Pharmaceuticals will not to make leadership changes at JB Chemicals and Pharmaceuticals, its management told investors in a call on Monday, a day after the announcement of its nearly Rs.19,500-crore deal to acquire a controlling stake.

Torrent said on Sunday that it would acquire a controlling stake in JB Pharma from global investment firm KKR, at an equity value of Rs.25,689 crore. The deal will be followed by a merger of the two entities. The deal is expected to be completed in 15-18 months, and is likely to be funded through debt.

"At this stage, all we can share is that there is no intention to change anything in business as usual," Aman Mehta, whole time director and managing ...